MCAM and breast carcinoma: Despite CD146 having been stated to be a tumor suppressor in breast cancer in certain studies, it is noteworthy that up-modulation of CD146 is frequently related to various high-grade tumors, ER-PR negative tumors and also triple negative breast cancers (TNBC) [13].